期刊文献+

Development of a new single dose extended release formulation of cefpodoxime proxetil

Development of a new single dose extended release formulation of cefpodoxime proxetil
下载PDF
导出
摘要 Objective:To develop floating microspheres of cefpodoxime proxetil(CP) in order to achieve an extended retention in the upper GIT for 12 hour.Methods:The microspheres were prepared by non aqueous solvent evaporation method using different ratios of cefpodoxime proxetil, hydroxyl propyl methyl cellulose(HPMC K4M ) and ethyl cellulose(1:1:1,1:1:2,1:1:3,1:1:4, 1:1:5 & 1:1:6),in the mixture of dichloromethane and ethanol at ratio of(l:l),with tween80 as the surfactant.Results:The floating microspheres was extended over 10-12 hours and were characterized by particle size analysis(75-600μm),buoyancy percentage(68.1%-85.4%), drug entrapment efficiency(67.5%-88.8%),%yield(50.50%-77.31%) and in vitro drug release was studied for 12 hours.Conclusions:The floating microspheres show better result and it may be use full for prolong the drug release in stomach and improve the bioavailability. Objective:To develop floating microspheres of cefpodoxime proxetil(CP) in order to achieve an extended retention in the upper GIT for 12 hour.Methods:The microspheres were prepared by non aqueous solvent evaporation method using different ratios of cefpodoxime proxetil, hydroxyl propyl methyl cellulose(HPMC K4M ) and ethyl cellulose(1:1:1,1:1:2,1:1:3,1:1:4, 1:1:5 & 1:1:6),in the mixture of dichloromethane and ethanol at ratio of(l:l),with tween80 as the surfactant.Results:The floating microspheres was extended over 10-12 hours and were characterized by particle size analysis(75-600μm),buoyancy percentage(68.1%-85.4%), drug entrapment efficiency(67.5%-88.8%),%yield(50.50%-77.31%) and in vitro drug release was studied for 12 hours.Conclusions:The floating microspheres show better result and it may be use full for prolong the drug release in stomach and improve the bioavailability.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2010年第2期117-120,共4页 亚太热带医药杂志(英文版)
关键词 FLOATING MICROSPHERES Cefpodoxime proxetil Single DOSE EXTENDED RELEASE FORMULATION Floating microspheres Cefpodoxime proxetil Single dose Extended release formulation
  • 相关文献

参考文献9

  • 1SS Davis.Formulation strategies for absorption windows. Drug Deliv Today . 2005
  • 2VK Kakumanu,V Arora,AK Bansal.Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil. International Journal of Pharmaceutics . 2006
  • 3Sylvie Crauste-Manciet Denis Brossard Marie-Odile Decroix Robert Farinotti and Jean-Claude Chaumeil.Cefpodoxime-proxetil protection from intestinal lumen hydrolysis by oil-in-water submicron emulsions. International Journal of Pharmaceutics .
  • 4Gerogiannis VS,Rekkas DM,Dallas PP,et al.Floating and swelling characteristics of various excipents used in controlled release technology. Drug Dev. And Pharm . 1993
  • 5Anand k.S.Floating microspheres of cimetidine: Formulation, characterization and in vitro evaluation. Acta Pharmacological Sinica . 2005
  • 6A. Patel,S. Ray,R. S. Thakur.In vitro evaluation and optimization of controlled release floating drug delivery system of metformin hydrochloride. Daru . 2006
  • 7TP Hadjiioannou,GD Christian,MA Koupparis,PE Macheras.Quantitative calculations in pharmaceutical practice and research. . 1993
  • 8Higuchi T.Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences . 1963
  • 9Sader HS,Jones RN,Washington JA,Murray PR,Gerlach E H,Allen SD,et al.In vitro activity of cefpodoxime compared with other oral cefphalosporins tested against 5 556 recent clinical isolates from five medical center. Diagnostic Microbiology and Infectious Disease . 1993

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部